stockrowClover Health Investments, Corp.
CLOV Healthcare Healthcare Plans
Clover Health Investments, Corp.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, up 40.3% from fiscal 2024.
- Revenue
- +52.9%
- EPS
- +350.0%
- Free cash flow
- +508.9%
Quarter to September 2026, against a year earlier
Follow CLOV
Alert me
Clover Health Investments, Corp. (CLOV) EV/EBITDA
As of 6 November 2026, Clover Health Investments, Corp. (CLOV) trades at a EV/EBITDA of 182×. Over the past ten years it has ranged from 0.0× (September 2026) to 183× (October 2026); the current reading is higher than 100% of that period. That is above the Healthcare Plans industry median of 12.6× and above the Healthcare sector median of 8.5×.
EV/EBITDA, daily
Embed this chart
Annual newest first
| Period | EV/EBITDA | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 0.0× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
Quarterly newest first
| Period | EV/EBITDA | Change |
|---|---|---|
| Sep 2026 | 162× | — |
| Jun 2026 | 0.0× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| 23 more quarters | Free account |
Against its own ten years
EV/EBITDA against peers
| Company | EV/EBITDA |
|---|---|
| CI Cigna Group compare | 8.1× |
| OSCR Oscar Health, Inc. compare | 8.6× |
| ELV Elevance Health, Inc. compare | 9.3× |
| CNC Centene Corporation compare | 11.8× |
| HUM Humana Inc. compare | 12.6× |
| ALHC Alignment Healthcare, Inc. compare | 14.5× |
| MOH Molina Healthcare, Inc compare | 18.2× |
| PGNY Progyny, Inc. compare | 20.9× |
| CLOV Clover Health Investments, Corp. | 182× |
| Healthcare Plans industry median | 12.6× |
| Healthcare sector median | 8.5× |
| Market median | 10.9× |
What EV/EBITDA is
Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)
More on CLOV
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement